Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucanthone with WBRT in NSCLC Brain Metastases
NCT02014545Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lucanthone in brain metastases, sponsored by Wake Forest University Health Sciences. Planned start Jan 2016; status: withdrawn.
02
Drugs
lucanthone
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT02014545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014545.